Trial Profile
Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2020
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 08 Jun 2020 Results published in the British Journal of Cancer
- 27 Mar 2020 Status changed from active, no longer recruiting to completed.
- 23 Oct 2018 Primary endpoint has not been met. (Progression-free survival rate at 9 months) as per the results presented at the 43rd European Society for Medical Oncology Congress.